The new way of Dabigatran reversal – Idarucizumab

Since last few years a popularity of new oral anticoagulants significantly raised. There are following main direct oral anticoagulants (DOAC) used in therapy: Dabigatran, Rywaroxaban, Apixaban, Endoxaban. Dabigatran (Pradaxa) is the first oral direct thrombin inhibitor approved by FDA in stroke prev...

Full description

Bibliographic Details
Main Authors: Erwin Ciechański, Krystian Ciechański, Magda Ciechańska, Jarosław Szponar
Format: Article
Language:English
Published: Kazimierz Wielki University 2019-02-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/25590